Mobile Device Surveying for Chronic Rhinosinusitis with Nasal Polyposis

Overview

About this study

The purpose of this study is to gather periodic quality of life data using the validated SNOT-22 protocol and/or other validated metrics using a free iPhone application for patients with Chronic Rhinosinusitis with Nasal Polyposis (CRSwNP).

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Adult patients (≥ 18 years old)
Chronic Rhinosinusitis with Nasal Polyposis (CRSwNP)
Access to a recent iOS device (such as iPhone, iPad or iPod touch)
Willing to follow-up with the Mayo Clinic (in person) for a minimum of 1 year.

Exclusion Criteria:

Physical or cognitive disabilities preventing use of an iOS device

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator Janalee Stokken, M.D.	Closed for enrollment

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

Janalee Stokken, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials